Key facts
- It has raised $28.3M; the latest was Later Stage VC ($28.3M) in Dec 2025.
- Notable investors include China National Biotec Group Company Limited, Huagai Capital, Huijin Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Geneodx Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Geneodx Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Geneodx Biotechnology
Manufacturer of in vitro diagnostic reagents and instruments designed to enable accurate and rapid disease detection. The company offers integrated molecular diagnostics, multiplex pathogen detection kits, and advanced diagnostic instruments, enabling hospitals, public health institutions, and clinical laboratories to achieve reliable diagnostic results and improved patient care.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 1991
- Employees
- 100
- Website
- geneodx.com/
- Ownership
- Privately Held (backing)
Geneodx Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Geneodx Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Geneodx Biotechnology in its N-PORT filings yet. We sweep new filings monthly.